tiprankstipranks
Advertisement
Advertisement

VTVT Stock Latest News

vTv Therapeutics initiated with a Buy at Rodman & Renshaw
The FlyvTv Therapeutics initiated with a Buy at Rodman & Renshaw
3d ago
VTVT
vTv Therapeutics Shareholders Approve Directors, Question Executive Pay
PremiumCompany Announcements
vTv Therapeutics Shareholders Approve Directors, Question Executive Pay
3d ago
8K
VTVT
vTv Therapeutics: Buy Rating Reiterated on Favorable Risk-Reward and Clinical Momentum; $67 Price Target Unchanged
PremiumRatings
vTv Therapeutics: Buy Rating Reiterated on Favorable Risk-Reward and Clinical Momentum; $67 Price Target Unchanged
2M ago
VTVT
Analyst Maintains Buy on vTv Therapeutics, Reiterates Unchanged $49 Price Target Amid Progress of Cadisegliatin Program
PremiumRatings
Analyst Maintains Buy on vTv Therapeutics, Reiterates Unchanged $49 Price Target Amid Progress of Cadisegliatin Program
2M ago
VTVT
vTv Therapeutics Expands At-The-Market Share Program Capacity
PremiumCompany Announcements
vTv Therapeutics Expands At-The-Market Share Program Capacity
2M ago
8K
VTVT
vTv Therapeutics reports Q1 EPS $1.65, consensus 21c
PremiumThe FlyvTv Therapeutics reports Q1 EPS $1.65, consensus 21c
2M ago
VTVT
vTv Therapeutics initiated with an Outperform at Evercore ISI
Premium
The Fly
vTv Therapeutics initiated with an Outperform at Evercore ISI
4M ago
VTVT
vTv Therapeutics price target raised to $55 from $35 at Alliance Global
Premium
The Fly
vTv Therapeutics price target raised to $55 from $35 at Alliance Global
4M ago
VTVT
Buy Rating on vTv Therapeutics Underpinned by Late-Stage T1D Catalyst, Strengthened Balance Sheet, and Diversified Partnership-Driven Upside
PremiumRatings
Buy Rating on vTv Therapeutics Underpinned by Late-Stage T1D Catalyst, Strengthened Balance Sheet, and Diversified Partnership-Driven Upside
4M ago
VTVT
vTv Therapeutics Highlights Cadisegliatin Phase 3 and Cash Runway
PremiumCompany Announcements
vTv Therapeutics Highlights Cadisegliatin Phase 3 and Cash Runway
4M ago
8K
VTVT
vTv Therapeutics reports Q4 EPS (58c), consensus ($1.09)
PremiumThe Fly
vTv Therapeutics reports Q4 EPS (58c), consensus ($1.09)
4M ago
VTVT
vTv Therapeutics Highlights Cadisegliatin Progress and Financial Strength
PremiumCompany Announcements
vTv Therapeutics Highlights Cadisegliatin Progress and Financial Strength
4M ago
8K
VTVT
vTv Therapeutics Inc. (VTVT) Q4 Earnings Cheat Sheet
PremiumPre-EarningsvTv Therapeutics Inc. (VTVT) Q4 Earnings Cheat Sheet
5M ago
VTVT
vTv Therapeutics Expands Global HPP737 Rights with Newsoara
Premium
Company Announcements
vTv Therapeutics Expands Global HPP737 Rights with Newsoara
5M ago
8K
VTVT
vTv Therapeutics expanded its license agreement with Newsoara Biopharma
Premium
The Fly
vTv Therapeutics expanded its license agreement with Newsoara Biopharma
5M ago
VTVT
vTv Therapeutics price target raised to $49 from $40 at BTIG
PremiumThe Fly
vTv Therapeutics price target raised to $49 from $40 at BTIG
5M ago
VTVT
vTv Therapeutics initiated with a Buy at Roth Capital
PremiumThe Fly
vTv Therapeutics initiated with a Buy at Roth Capital
5M ago
VTVT
vTv Therapeutics: Late-Stage Cadisegliatin Data, Differentiated Mechanism, and Partnered T2D Expansion Underpin Buy Rating and $40 Target
PremiumRatings
vTv Therapeutics: Late-Stage Cadisegliatin Data, Differentiated Mechanism, and Partnered T2D Expansion Underpin Buy Rating and $40 Target
6M ago
VTVT
vTv Therapeutics initiated with a Buy at TD Cowen
PremiumThe Fly
vTv Therapeutics initiated with a Buy at TD Cowen
6M ago
VTVT
Paradigm-Shifting Potential in Type 1 Diabetes: vTv Therapeutics’ Cadisegliatin Supports Buy Rating and Significant Upside
PremiumRatingsParadigm-Shifting Potential in Type 1 Diabetes: vTv Therapeutics’ Cadisegliatin Supports Buy Rating and Significant Upside
6M ago
VTVT
vTv Therapeutics price target raised to $47 from $36 at H.C. Wainwright
Premium
The Fly
vTv Therapeutics price target raised to $47 from $36 at H.C. Wainwright
7M ago
VTVT
vTv submits cadisegliatin study protocol to Department of Health Abu Dhabi
Premium
The Fly
vTv submits cadisegliatin study protocol to Department of Health Abu Dhabi
7M ago
VTVT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >